HHS on Monday launched a new program to spur development and commercialization of technologies that would help the U.S. respond to health security threats and disasters.
The Foundry for American Biotechnology, a public-private partnership, will be jointly managed by the department’s Office of the Assistant Secretary for Preparedness and Response—or ASPR—and the New Hampshire technology firm Deka Research and Development Corp.
{iframe}https://www.modernhealthcare.com/operations/new-hhs-effort-develop-commercialize-biotech-innovations{/iframe}